These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7035640)

  • 21. Gentamicin disposition kinetics in humans with spinal cord injury.
    Segal JL; Gray DR; Gordon SK; Eltorai IM; Khonsari F; Patel J
    Paraplegia; 1985 Feb; 23(1):47-55. PubMed ID: 3982847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
    Jiao Y; Kim TH; Tao X; Kinzig M; Landersdorfer CB; Drescher SK; Sutaria DS; Moya B; Holzgrabe U; Sörgel F; Bulitta JB
    Eur J Pharm Sci; 2018 Oct; 123():416-428. PubMed ID: 30076955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gentamicin dosing in the newborn. Use of a one-compartment open pharmacokinetic model to individualize dosing.
    Edgren B; Karna P; Sciamanna D; Dolanski E
    Dev Pharmacol Ther; 1984; 7(4):263-72. PubMed ID: 6468228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
    Kirkpatrick CM; Duffull SB; Begg EJ
    Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erratum: renal clearance of gentamicin in cystic fibrosis.
    MacDonald NE
    J Pediatr; 1984 Oct; 105(4):673. PubMed ID: 6481550
    [No Abstract]   [Full Text] [Related]  

  • 26. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
    Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
    Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal clearance and tissue accumulation of gentamicin.
    Schentag JJ; Jusko WJ
    Clin Pharmacol Ther; 1977 Sep; 22(3):364-70. PubMed ID: 330081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration of gentamicin in bronchial secretions of children with cystic fibrosis of tracheostomy. (Comparison between the intramuscular route, the endotracheal instillation and aerosolization).
    Baran D; Dachy A; Klastersky J
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):336-41. PubMed ID: 809371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic adjustment of gentamicin dosing in horses with sepsis.
    Sojka JE; Brown SA
    J Am Vet Med Assoc; 1986 Oct; 189(7):784-9. PubMed ID: 3771340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceftazidime disposition in acute and stable cystic fibrosis.
    Leeder JS; Spino M; Isles AF; Tesoro AM; Gold R; MacLeod SM
    Clin Pharmacol Ther; 1984 Sep; 36(3):355-62. PubMed ID: 6432400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
    Lim AK; Mathanasenarajah G; Larmour I
    Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gentamicin pharmacokinetics in adults with bacterial endocarditis.
    Rosell-Rovira ML; Pou-Clavé L; García-Beltran L; Pascual-Mostaza C
    Am J Hosp Pharm; 1994 Jun; 51(11):1429-32. PubMed ID: 7942877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiexponential elimination of gentamicin. A kinetic study during development.
    Assael BM; Cavanna G; Jusko WJ; Marini A; Parini R; Sereni F; Viganò A
    Dev Pharmacol Ther; 1980; 1(2-3):171-81. PubMed ID: 6927546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of gentamicin during peritoneal dialysis in children.
    Jusko WJ; Baliah T; Kim KH; Gerbracht LM; Yaffe SJ
    Kidney Int; 1976 May; 9(5):430-8. PubMed ID: 940277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of gentamicin in children with nephrotic syndrome.
    González-Martin G; Bravo I; Vargas H; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):555-8. PubMed ID: 3781676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
    Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
    J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of thyroid function on the pharmacokinetics of gentamicin in pigs.
    Riond JL; Dix LP; Riviere JE
    Am J Vet Res; 1986 Oct; 47(10):2141-6. PubMed ID: 3777637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosage schedule of gentamicin for chronic renal insufficiency in children.
    Yoshioka H; Takimoto M; Matsuda I; Hattori S
    Arch Dis Child; 1978 Apr; 53(4):334-7. PubMed ID: 646447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gentamicin disposition in children with chronic renal failure.
    Berry PL; Kearns GL; Brown RD; Ritschel WA; Thompson GA; McEnery PT
    Pediatr Pharmacol (New York); 1982; 2(4):257-73. PubMed ID: 6927126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single intravenous and multiple dose pharmacokinetics of gentamicin in healthy llamas.
    Lackey MN; Belknap EB; Greco DS; Fettman MJ
    Am J Vet Res; 1996 Aug; 57(8):1193-9. PubMed ID: 8836374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.